Error message

The page you requested does not exist. For your convenience, a search was performed using the query Surgical Oncology.

Page not found

Search results

  1. Swim with the Funds: The story of funding from those who succeeded

    of Nodality, Inc., a private company focused on innovative personalized medicine approaches in oncology ... , immunology and immuno-oncology. Prior to joining Nodality, Ms. Brege held several senior-level positions ... at Onyx Pharmaceuticals, Inc., a global oncology company, including Executive Vice President and Chief ...

  2. [Irvine Session] From Chemical to Drug: The Path to a Small Molecule IND

    Oncology lead for ibrutinib, a first-in-class BTK inhibitor jointly developed and marketed ... therapeutic areas including metabolic diseases, neuroscience, immunology, neuroscience and oncology ... and cardiovascular diseases, immunology, neuroscience and oncology. Additionally, she has lead staff supporting ...

  3. From Chemical to Drug: The Path to a Small Molecule IND

    Oncology lead for ibrutinib, a first-in-class BTK inhibitor jointly developed and marketed ... metabolic diseases, neuroscience, immunology, neuroscience and oncology. In addition to Silvia’s Regulatory ... immunology, neuroscience and oncology. Additionally, she has lead staff supporting toxicology and DMPK project ...

  4. From Chemical to Drug- The Path to a Small Molecule IND

    to clinical development to become the ClinPharm Oncology lead for ibrutinib, a first-in-class BTK inhibitor ... and oncology. In addition to Silvia's Regulatory experience, she has worked in Quality Assurance. ... and cardiovascular diseases, immunology, neuroscience and oncology. Additionally, she has lead staff supporting ...

  5. Funding in Biotech: What Lies Ahead for 2013?

    sclerosis and oncology. He held that position from December 2008 until the company’s acquisition by Abbott ... of the oncology/rheumatology strategic business unit. Prior to Biogen Idec, Hasnain held roles with Bristol-Myers Squibb, where ... he was President of the Oncology Therapeutics Network, and for 14 years at GlaxoSmithKline and its ...

  6. Meet with... Johnson & Johnson Innovation

    & Johnson Innovation, Boston. He focuses primarily on the areas of Oncology and Immunology. ... on the areas of Immunology, Inflammation and Oncology and has a passion for implementing cutting edge ... on the leadership of the newly formed Oncology Research group at Centocor. In 2007, Marian joined the Business ...

  7. [Irvine Session] From Chemical to Drug: The Path to a Small Molecule IND

    Oncology lead for ibrutinib, a first-in-class BTK inhibitor jointly developed and marketed ... therapeutic areas including metabolic diseases, neuroscience, immunology, neuroscience and oncology ... and cardiovascular diseases, immunology, neuroscience and oncology. Additionally, she has lead staff supporting ...

  8. From Chemical to Drug: The Path to a Small Molecule IND

    Oncology lead for ibrutinib, a first-in-class BTK inhibitor jointly developed and marketed ... metabolic diseases, neuroscience, immunology, neuroscience and oncology. In addition to Silvia’s Regulatory ... immunology, neuroscience and oncology. Additionally, she has lead staff supporting toxicology and DMPK project ...

  9. From Chemical to Drug- The Path to a Small Molecule IND

    to clinical development to become the ClinPharm Oncology lead for ibrutinib, a first-in-class BTK inhibitor ... and oncology. In addition to Silvia's Regulatory experience, she has worked in Quality Assurance. ... and cardiovascular diseases, immunology, neuroscience and oncology. Additionally, she has lead staff supporting ...

  10. [NYC session] From Chemical to Drug- The Path to a Small Molecule IND

    in the Cardiovascular and Metabolism, Immunology, Neuroscience, and Oncology therapeutic areas. In addition to using ... of this role, he is responsible for a portfolio of discovery and development projects in the Oncology ... to facilitate clinical drug development and approval in cardiovascular, metabolic, immunology, and oncology ...

Pages

Share